Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers

2010

Findings suggest activation of an anti-oncogenic protein phosphatase as a strategy to treat drug-resistant cancers driven by the c-KIT oncogene.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

52

References

105

Citations